These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Third-generation oral contraceptives: how risky? Weiss N Lancet; 1995 Dec; 346(8990):1570. PubMed ID: 7500743 [TBL] [Abstract][Full Text] [Related]
25. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives. Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614 [TBL] [Abstract][Full Text] [Related]
26. Increased risk of thrombosis due to oral contraceptives: a further report. Maguire MG; Tonascia J; Sartwell PE; Stolley PD; Tockman MS Am J Epidemiol; 1979 Aug; 110(2):188-95. PubMed ID: 463873 [TBL] [Abstract][Full Text] [Related]
27. Splenic artery thrombosis secondary to oral contraceptive medication: case report. Weinstein E; Silverman L Mil Med; 1982 Jul; 147(7):589-90. PubMed ID: 6815581 [TBL] [Abstract][Full Text] [Related]
32. Risk of fatal pulmonary embolism with oral contraceptives. Poulter NR Lancet; 2000 Jun; 355(9221):2088. PubMed ID: 10902616 [TBL] [Abstract][Full Text] [Related]
33. Influence of augmented Hageman factor (Factor XII) titers on the cryoactivation of plasma prorenin in women using oral contraceptive agents. Gordon EM; Douglas J; Ratnoff OD J Clin Invest; 1983 Nov; 72(5):1833-8. PubMed ID: 6355187 [TBL] [Abstract][Full Text] [Related]
34. Oral contraceptives and venous thromboembolism: a case-control study designed to minimize detection bias. Realini JP; Encarnacion CE; Chintapalli KN; Rees CR J Am Board Fam Pract; 1997; 10(5):315-21. PubMed ID: 9297655 [TBL] [Abstract][Full Text] [Related]
35. Factor V Leiden: should we screen oral contraceptive users and pregnant women? Vandenbroucke JP; van der Meer FJ; Helmerhorst FM; Rosendaal FR BMJ; 1996 Nov; 313(7065):1127-30. PubMed ID: 8916702 [TBL] [Abstract][Full Text] [Related]
36. Thromboembolic disease associated with norethynodrel: report of six cases. Schatz IJ; Smith RF; Breneman GM; Bower GC JAMA; 1964 May; 188(6):493-5. PubMed ID: 12255392 [TBL] [Abstract][Full Text] [Related]
37. Cerebral vein thrombosis and the contraceptive pill in paroxysmal nocturnal haemoglobinuria. Stirling ML; Lenton RJ; Sumerling MD Scott Med J; 1980 Jul; 25(3):243-4. PubMed ID: 7444435 [TBL] [Abstract][Full Text] [Related]
38. Letter: Oral contraceptives in women over 34. Guillebaud J Br Med J; 1975 Nov; 4(5994):457-8. PubMed ID: 1192116 [TBL] [Abstract][Full Text] [Related]
39. Oral contraceptives, venous thrombosis, and varicose veins. Royal College of General Practitioners' Oral Contraception Study. J R Coll Gen Pract; 1978 Jul; 28(192):393-9. PubMed ID: 702453 [TBL] [Abstract][Full Text] [Related]
40. Cardiovascular effects of oral contraceptives: a review. Stubblefield PG Int J Fertil; 1989; 34 Suppl():40-9. PubMed ID: 2576258 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]